Amarantus Bioscience Holdings Inc banner

Amarantus Bioscience Holdings Inc
OTC:AMBS

Watchlist Manager
Amarantus Bioscience Holdings Inc Logo
Amarantus Bioscience Holdings Inc
OTC:AMBS
Watchlist
Price: 0 USD Market Closed
Market Cap: $0

Income Statement

Earnings Waterfall
Amarantus Bioscience Holdings Inc

Income Statement
Amarantus Bioscience Holdings Inc

Rotate your device to view
Income Statement
Currency: USD
Oct-2008 Jan-2009 Apr-2009 Jul-2009 Oct-2009 Jan-2010 Apr-2010 Jul-2010 Oct-2010 Jan-2011 Apr-2011 Jun-2011 Sep-2011 Dec-2011 Mar-2012 Jun-2012 Sep-2012 Dec-2012 Mar-2013 Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016
Revenue
Interest Expense
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
2
2
2
3
3
2
2
2
1
0
0
0
2
3
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
+459%
0
-78%
0
N/A
0
-80%
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Gross Profit
Cost of Revenue
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(2)
(4)
(5)
(5)
(5)
(4)
(5)
(5)
(5)
(6)
(5)
(15)
(18)
(21)
(28)
(36)
(35)
(25)
(27)
Selling, General & Administrative
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(3)
(4)
(4)
(4)
(4)
(3)
(4)
(4)
(4)
(4)
(5)
(6)
(8)
(11)
(16)
(16)
(12)
(13)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(3)
(5)
(14)
(16)
(19)
(18)
(13)
(15)
Depreciation & Amortization
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(7)
(7)
0
0
0
0
0
0
Operating Income
(0)
N/A
(0)
-50%
(0)
+33%
(0)
+50%
(0)
-100%
(0)
N/A
(0)
-50%
(0)
-67%
(0)
-17%
(0)
-54%
(0)
+11%
(1)
-1 338%
(2)
-38%
(4)
-135%
(5)
-30%
(5)
+3%
(5)
-3%
(4)
+16%
(5)
-13%
(5)
-8%
(5)
-2%
(6)
-13%
(5)
+4%
(15)
-168%
(18)
-23%
(21)
-19%
(28)
-29%
(36)
-31%
(35)
+1%
(25)
+30%
(27)
-11%
Pre-Tax Income
Interest Income Expense
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(4)
(4)
(6)
(2)
(3)
(3)
(1)
(0)
(1)
(0)
(1)
2
3
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(7)
(7)
0
0
(1)
0
0
0
(1)
(1)
Total Other Income
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
0
0
0
(0)
(0)
(0)
(0)
(0)
(4)
(4)
(5)
(4)
(0)
(0)
(2)
(1)
(1)
Pre-Tax Income
(0)
N/A
(0)
-50%
(0)
+33%
(0)
+50%
(0)
-100%
(0)
N/A
(0)
-50%
(0)
-67%
(0)
-17%
(0)
-54%
(0)
+11%
(1)
-1 388%
(2)
-55%
(4)
-141%
(6)
-27%
(6)
+2%
(5)
+2%
(5)
+5%
(8)
-65%
(9)
-2%
(11)
-29%
(15)
-36%
(19)
-26%
(22)
-15%
(23)
-6%
(27)
-17%
(28)
-4%
(37)
-29%
(38)
-3%
(25)
+33%
(27)
-6%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Income from Continuing Operations
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(2)
(4)
(6)
(6)
(5)
(5)
(8)
(9)
(11)
(15)
(19)
(22)
(23)
(27)
(28)
(37)
(38)
(25)
(27)
Net Income (Common)
(0)
N/A
(0)
-50%
(0)
+33%
(0)
+50%
(0)
-100%
(0)
N/A
(0)
-50%
(0)
-67%
(0)
-17%
(0)
-54%
(0)
+11%
(1)
-1 388%
(2)
-55%
(4)
-141%
(6)
-27%
(6)
+2%
(5)
+2%
(5)
+5%
(8)
-65%
(9)
-2%
(11)
-29%
(15)
-36%
(19)
-27%
(22)
-15%
(23)
-6%
(28)
-20%
(30)
-7%
(42)
-41%
(46)
-8%
(37)
+19%
(50)
-34%
EPS (Diluted)
-0.01
N/A
-0.02
-100%
-0.01
+50%
0
N/A
-0.01
N/A
0
N/A
-0.01
N/A
-0.02
-100%
-0.03
-50%
-0.05
-67%
-0.05
N/A
-3.21
-6 320%
-4.08
-27%
-12.65
-210%
-9.59
+24%
-9.85
-3%
-7.21
+27%
-5.48
+24%
-3.44
+37%
-3.26
+5%
-3.49
-7%
-5.05
-45%
-4.57
+10%
-3.86
+16%
-4.57
-18%
-5.35
-17%
-3.77
+30%
-5.57
-48%
-5.7
-2%
-4.17
+27%
-1.47
+65%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett